UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NetEase
NTES
|
+$336M |
| 2 |
AbbVie
ABBV
|
+$235M |
| 3 |
VMW
VMware, Inc
VMW
|
+$163M |
| 4 |
T-Mobile US
TMUS
|
+$156M |
| 5 |
Aptiv
APTV
|
+$154M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$570M |
| 2 |
Microsoft
MSFT
|
+$506M |
| 3 |
Apple
AAPL
|
+$394M |
| 4 |
Abbott
ABT
|
+$262M |
| 5 |
Intel
INTC
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.77% |
| 2 | Healthcare | 13.92% |
| 3 | Consumer Discretionary | 13.52% |
| 4 | Financials | 11.89% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2026
Gossamer Bio
GOSS
$87M
| $560K | ﹤0.01% |
43,052
+31,852
| +284% | +$401K |
|
2027
Tompkins Financial
TMP
$1.42B
| $557K | ﹤0.01% |
8,600
-1,249
| -13% | -$81.5K |
|
2028
Preferred Bank
PFBC
$1.25B
| $557K | ﹤0.01% |
12,992
+634
| +5% | +$23.3K |
|
|
CMO
2029
DELISTED
Capstead Mortgage Corp.
CMO
| $556K | ﹤0.01% |
101,257
-16,570
| -14% | -$83.2K |
|
2030
StoneX
SNEX
$7.94B
| $555K | ﹤0.01% |
51,071
-5,988
| -10% | -$51.9K |
|
|
WIRE
2031
DELISTED
Encore Wire Corp
WIRE
| $555K | ﹤0.01% |
11,365
+3,799
| +50% | +$174K |
|
2032
HealthStream
HSTM
$840M
| $553K | ﹤0.01% |
24,971
+5,231
| +26% | +$121K |
|
|
ENDP
2033
DELISTED
Endo International plc
ENDP
| $551K | ﹤0.01% |
160,775
-20,455
| -11% | -$78.3K |
|
2034
W&T Offshore
WTI
$518M
| $551K | ﹤0.01% |
241,854
+63,733
| +36% | +$162K |
|
2035
Pathward Financial
CASH
$1.8B
| $551K | ﹤0.01% |
30,320
-2,141
| -7% | -$37.5K |
|
2036
Evolent Health
EVH
$447M
| $550K | ﹤0.01% |
77,198
+8,566
| +12% | +$57.4K |
|
|
KNL
2037
DELISTED
Knoll, Inc.
KNL
| $550K | ﹤0.01% |
45,089
-9,043
| -17% | -$99.5K |
|
|
POLY
2038
DELISTED
Plantronics, Inc.
POLY
| $548K | ﹤0.01% |
37,354
+3,830
| +11% | +$49.9K |
|
2039
The Bancorp
TBBK
$2.84B
| $548K | ﹤0.01% |
55,880
-4,644
| -8% | -$35K |
|
2040
Vanda Pharmaceuticals
VNDA
$302M
| $547K | ﹤0.01% |
47,850
+2,814
| +6% | +$31.9K |
|
|
LGF.A
2041
DELISTED
Lions Gate Entertainment Corp. Class A Voting Shares
LGF.A
| $547K | ﹤0.01% |
73,847
+5,679
| +8% | +$42.1K |
|
2042
Standex International
SXI
$4.12B
| $547K | ﹤0.01% |
9,497
+4,523
| +91% | +$229K |
|
2043
CTS Corp
CTS
$1.89B
| $546K | ﹤0.01% |
27,267
+318
| +1% | +$6.81K |
|
|
GBIO
2044
DELISTED
Generation Bio
GBIO
| $546K | ﹤0.01% |
+2,600
| New | +$579K |
|
2045
Amneal Pharmaceuticals
AMRX
$5.79B
| $545K | ﹤0.01% |
114,514
-2,214
| -2% | -$9.12K |
|
|
FLXN
2046
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $545K | ﹤0.01% |
41,432
+4,513
| +12% | +$46.8K |
|
2047
CorVel
CRVL
$3.19B
| $545K | ﹤0.01% |
23,052
+8,742
| +61% | +$172K |
|
|
TCDA
2048
DELISTED
Tricida, Inc. Common Stock
TCDA
| $544K | ﹤0.01% |
+19,791
| New | +$539K |
|
2049
Phreesia
PHR
$773M
| $542K | ﹤0.01% |
+19,175
| New | +$499K |
|
2050
St. Joe Company
JOE
$3.83B
| $542K | ﹤0.01% |
27,909
-10,251
| -27% | -$189K |
|
Similar funds
UBS AM's Q2 2020 Portfolio in Review
As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.
- UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
- UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
- UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
- UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
- UBS AM opened 144 new positions and closed 142 in Q2 2020.
- UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.
Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.